Methadone Hydrochloride Ascot Laboratories

Methadone Hydrochloride, the active ingredient in Methadone Hydrochloride Ascot Laboratories, is a synthetic opioid presented as an oral formulation for oral use. It is employed in the management of opioid dependence and in the treatment of chronic pain in adult patients.

GNH USA supplies Methadone Hydrochloride Ascot Laboratories as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support import and distribution. Customer support is available to address technical queries and ensure reliable supply chain management.

Methadone Hydrochloride is a synthetic opioid used in opioid receptor modulation for dependence and pain management. - Opioid dependence treatment: reduces withdrawal symptoms and cravings, supporting maintenance therapy. - Opioid withdrawal management: stabilizes patients during detoxification by providing a controlled opioid dose. - Chronic pain: delivers long‑acting analgesia for severe, persistent pain when other opioids are inadequate.

Methadone Hydrochloride may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Constipation: reduced bowel movements. - Drowsiness: increased sleepiness or fatigue. - Sweating: excessive perspiration.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing, potentially life‑threatening. - Cardiac arrhythmia: abnormal heart rhythm, including QT prolongation. - Severe allergic reaction: rash, itching, swelling, or anaphylaxis.

When prescribing Methadone Hydrochloride, clinicians should observe several safety precautions to minimize risk. - Assess patient history: evaluate prior opioid use, respiratory disorders, and cardiac conditions. - Monitor dosing: adjust gradually and observe for signs of over‑sedation or accumulation. - Avoid concurrent CNS depressants: limit use with alcohol, benzodiazepines, or other sedatives. - Conduct ECG monitoring: check QT interval in patients with cardiac risk factors. - Educate patients: inform about signs of overdose and the importance of adherence. - Store at ambient temperature: keep below 25 °C in the original container, protected from moisture and light.

Methadone Hydrochloride can interact with several medications, altering its effects or increasing toxicity.

Major Interactions (Avoid): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): can raise methadone plasma levels, increasing overdose risk. - QT‑prolonging drugs (e.g., quinidine, haloperidol): may exacerbate cardiac arrhythmia risk. - CNS depressants (e.g., benzodiazepines, barbiturates): potentiate respiratory depression.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin, carbamazepine): may lower methadone concentrations, reducing efficacy. - Antiretrovirals (e.g., efavirenz): can affect methadone metabolism, requiring dose adjustments. - Herbal supplements (e.g., St. John’s wort): may decrease methadone levels.